Prediction of Amino Acid Substitutions in ABL1 Protein Leading to Tumor Drug Resistance Based on “Structure-Property” Relationship Classification Models

Drug resistance to anticancer drugs is a serious complication in patients with cancer. Typically, drug resistance occurs due to amino acid substitutions (AAS) in drug target proteins. The study aimed at developing and validating a new approach to the creation of structure-property relationships (SPR...

Full description

Bibliographic Details
Main Authors: Svetlana I. Zhuravleva, Anton D. Zadorozhny, Boris V. Shilov, Alexey A. Lagunin
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/9/1807
_version_ 1797579170286403584
author Svetlana I. Zhuravleva
Anton D. Zadorozhny
Boris V. Shilov
Alexey A. Lagunin
author_facet Svetlana I. Zhuravleva
Anton D. Zadorozhny
Boris V. Shilov
Alexey A. Lagunin
author_sort Svetlana I. Zhuravleva
collection DOAJ
description Drug resistance to anticancer drugs is a serious complication in patients with cancer. Typically, drug resistance occurs due to amino acid substitutions (AAS) in drug target proteins. The study aimed at developing and validating a new approach to the creation of structure-property relationships (SPR) classification models to predict AASs leading to drug resistance to inhibitors of tyrosine-protein kinase ABL1. The approach was based on the representation of AASs as peptides described in terms of structural formulas. The data on drug-resistant and non-resistant variants of AAS for two isoforms of ABL1 were extracted from the COSMIC database. The given training sets (approximately 700 missense variants) were used for the creation of SPR models in MultiPASS software based on substructural atom-centric multiple neighborhoods of atom (MNA) descriptors for the description of the structural formula of protein fragments and a Bayesian-like algorithm for revealing structure-property relationships. It was found that MNA descriptors of the 6th level and peptides from 11 amino acid residues were the best combination for ABL1 isoform 1 with the prediction accuracy (AUC) of resistance to imatinib (0.897) and dasatinib (0.996). For ABL1 isoform 2 (resistance to imatinib), the best combination was MNA descriptors of the 6th level, peptides form 15 amino acids (AUC value was 0.909). The prediction of possible drug-resistant AASs was made for dbSNP and gnomAD data. The six selected most probable imatinib-resistant AASs were additionally validated by molecular modeling and docking, which confirmed the possibility of resistance for the E334V and T392I variants.
first_indexed 2024-03-10T22:33:05Z
format Article
id doaj.art-7928706d4fe0491fb310e9323029a73d
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-10T22:33:05Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-7928706d4fe0491fb310e9323029a73d2023-11-19T11:36:34ZengMDPI AGLife2075-17292023-08-01139180710.3390/life13091807Prediction of Amino Acid Substitutions in ABL1 Protein Leading to Tumor Drug Resistance Based on “Structure-Property” Relationship Classification ModelsSvetlana I. Zhuravleva0Anton D. Zadorozhny1Boris V. Shilov2Alexey A. Lagunin3Department of Bioinformatics, Pirogov Russian National Research Medical University, 117997 Moscow, RussiaDepartment of Bioinformatics, Pirogov Russian National Research Medical University, 117997 Moscow, RussiaDepartment of Bioinformatics, Pirogov Russian National Research Medical University, 117997 Moscow, RussiaDepartment of Bioinformatics, Pirogov Russian National Research Medical University, 117997 Moscow, RussiaDrug resistance to anticancer drugs is a serious complication in patients with cancer. Typically, drug resistance occurs due to amino acid substitutions (AAS) in drug target proteins. The study aimed at developing and validating a new approach to the creation of structure-property relationships (SPR) classification models to predict AASs leading to drug resistance to inhibitors of tyrosine-protein kinase ABL1. The approach was based on the representation of AASs as peptides described in terms of structural formulas. The data on drug-resistant and non-resistant variants of AAS for two isoforms of ABL1 were extracted from the COSMIC database. The given training sets (approximately 700 missense variants) were used for the creation of SPR models in MultiPASS software based on substructural atom-centric multiple neighborhoods of atom (MNA) descriptors for the description of the structural formula of protein fragments and a Bayesian-like algorithm for revealing structure-property relationships. It was found that MNA descriptors of the 6th level and peptides from 11 amino acid residues were the best combination for ABL1 isoform 1 with the prediction accuracy (AUC) of resistance to imatinib (0.897) and dasatinib (0.996). For ABL1 isoform 2 (resistance to imatinib), the best combination was MNA descriptors of the 6th level, peptides form 15 amino acids (AUC value was 0.909). The prediction of possible drug-resistant AASs was made for dbSNP and gnomAD data. The six selected most probable imatinib-resistant AASs were additionally validated by molecular modeling and docking, which confirmed the possibility of resistance for the E334V and T392I variants.https://www.mdpi.com/2075-1729/13/9/1807sequence-structure analysisdrug resistancemolecular fragmentsMNA descriptorsMultiPASSamino acid substitution
spellingShingle Svetlana I. Zhuravleva
Anton D. Zadorozhny
Boris V. Shilov
Alexey A. Lagunin
Prediction of Amino Acid Substitutions in ABL1 Protein Leading to Tumor Drug Resistance Based on “Structure-Property” Relationship Classification Models
Life
sequence-structure analysis
drug resistance
molecular fragments
MNA descriptors
MultiPASS
amino acid substitution
title Prediction of Amino Acid Substitutions in ABL1 Protein Leading to Tumor Drug Resistance Based on “Structure-Property” Relationship Classification Models
title_full Prediction of Amino Acid Substitutions in ABL1 Protein Leading to Tumor Drug Resistance Based on “Structure-Property” Relationship Classification Models
title_fullStr Prediction of Amino Acid Substitutions in ABL1 Protein Leading to Tumor Drug Resistance Based on “Structure-Property” Relationship Classification Models
title_full_unstemmed Prediction of Amino Acid Substitutions in ABL1 Protein Leading to Tumor Drug Resistance Based on “Structure-Property” Relationship Classification Models
title_short Prediction of Amino Acid Substitutions in ABL1 Protein Leading to Tumor Drug Resistance Based on “Structure-Property” Relationship Classification Models
title_sort prediction of amino acid substitutions in abl1 protein leading to tumor drug resistance based on structure property relationship classification models
topic sequence-structure analysis
drug resistance
molecular fragments
MNA descriptors
MultiPASS
amino acid substitution
url https://www.mdpi.com/2075-1729/13/9/1807
work_keys_str_mv AT svetlanaizhuravleva predictionofaminoacidsubstitutionsinabl1proteinleadingtotumordrugresistancebasedonstructurepropertyrelationshipclassificationmodels
AT antondzadorozhny predictionofaminoacidsubstitutionsinabl1proteinleadingtotumordrugresistancebasedonstructurepropertyrelationshipclassificationmodels
AT borisvshilov predictionofaminoacidsubstitutionsinabl1proteinleadingtotumordrugresistancebasedonstructurepropertyrelationshipclassificationmodels
AT alexeyalagunin predictionofaminoacidsubstitutionsinabl1proteinleadingtotumordrugresistancebasedonstructurepropertyrelationshipclassificationmodels